Grants and Contributions:

Title:

UKRI Biomanufacturing - 10101911 Novel VVP Platform - Next generation high-yield producer platform for cell and gene therapy viral vectors and other complex biologics

Agreement Number:

1019854

Agreement Value:

$320,600.00

Agreement Date:

Jun 3, 2024 - Jun 5, 2026

Description:

This project focuses on increasing viral vector productivity at least 50-100 folds higher by the genetic modification of the 293-cell line targeting genes with crucial role in viral vector production and quality. It is being carried under the IRAP International Program: Canada-UK Biomanufacturing in collaboration with UK partners HexagonFab and Revvity.

Organization:

National Research Council Canada

Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Location:

Beaconsfield, Quebec, CA H9W 6C9

Reference Number:

172-2024-2025-Q2-1019854

Agreement Type:

Contribution

Report Type:

Grants and Contributions

Recipient Business Number:

724228879

Recipient Type:

For-profit organization

Recipient's Operating Name:

Vvector Bio Inc

Recipient's Legal Name:

VVecteur Bio Inc.

Federal Riding Name:

Lac-Saint-Louis

Federal Riding Number:

24036

Program:

Industrial Research Assistance Program – Contributions to Firms

Program Purpose:

Coverage:

IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.

NAICS Code:

325410